Menu Search
Equities

Dis-Chem Pharmacies Ltd

DCP:JNB

Dis-Chem Pharmacies Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (ZAX)3,745.00
  • Today's Change23.00 / 0.62%
  • Shares traded147.45k
  • 1 Year change+29.36%
  • Beta0.2558
Data delayed at least 15 minutes, as of Nov 22 2024 11:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy2
Outperform2
Hold2
Sell1
Strong Sell0

Share price forecast in ZAR

The 6 analysts offering 12 month price targets for Dis-Chem Pharmacies Ltd have a median target of 4,000.00, with a high estimate of 4,300.00 and a low estimate of 3,500.00. The median estimate represents a 7.47% increase from the last price of 3,722.00.
High15.5%4,300.00
Med7.5%4,000.00
Low-6.0%3,500.00

Dividends in ZAR

In 2024, Dis-Chem Pharmacies Ltd reported a dividend of 0.46 ZAR, which represents a 1.80% decrease from last year. The 7 analysts covering the company expect dividends of 0.56 ZAR for the upcoming fiscal year, an increase of 22.44%.
Div growth (TTM)-1.80%
More ▼

Earnings history & estimates in ZAR

Dis-Chem Pharmacies Ltd reported annual 2024 earnings of 1.15 per share on May 31, 2024.
Average growth rate+13.60%
More ▼

Revenue history & estimates in ZAR

Dis-Chem Pharmacies Limited had revenues for the full year 2024 of 36.28bn. This was 11.08% above the prior year's results.
Average growth rate+10.94%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.